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SINTESIS SISTEM PENGHANTARAN UBAT NANOKOLOID SILIKA 
MENGGUNAKAN PENDEKATAN PEMBENTUKAN MISEL 
 
ABSTRAK 
 Nanopartikel (NPs) silika koloid telah disintesis dengan menggunakan 
pendekatan pembentukan misel. Kaedah ini sangat bermanfaat bagi menghasilkan 
NPs silika taburan sekata dengan pelbagai saiz dari 20-160 nm dengan mengubah 
suhu tindak balas dan jumlah pelarut bersama 2-butanol. Surfaktan bukan ionic 
Tween 80 telah digunakan untuk membentuk struktur misel bagi memerangkap ubat 
dan secara langsung membantu dalam pembentukan NPs silika sfera koloid. 
Berbanding dengan kaedah lain, kaedah ini menawarkan proses memuatkan ubat 
yang mudah di mana molekul ubat akan terus terperangkap di dalam struktur misel 
sebelum NPs silika terbentuk. Dalam kerja ini, hanya sejumlah kecil surfaktan telah 
digunakan tanpa perangkap tambahan. Selain itu, kadar kejayaan memerangkap ubat 
di dalam NPs silika sangat memberangsangkan dengan penyingkiran surfaktan telah 
dilengkapkan dengan proses dialisis yang tidak menjejaskan sifat-sifat NPs silika 
koloid. Jumlah optimum Si prekursor (VTMS) adalah 2 ml. Meningkatkan jumlah Si 
prekursor akan menghasilkan taburan bimodal. Dua ubat Tuberculosis, Isoniazid 
(larut air) dan Rifampicin (kurang larut air) telah dipilih sebagai model ubat. 
Kestabilan 50 nm dan 70 nm NPs silika dengan ubat Rifampicin terperangkap 
(SiRIF) di dalam NaCl dan serum tikus dengan pelbagai kepekatan telah diuji. Profil 
pelepasan 50 nm dan 70 nm SiRIF di dalam pelbagai kepekatan PBS dan pH (1.4, 
6.8 dan 7.4) telah dibandingkan. 70 nm SiRIF menunjukkan pelepasan yang perlahan 
(31%) berbanding dengan 50 nm SiRIF (44%) selama 5 hari. Keputusan IC50 dari 
ujian ketoksikan WST-1 ke atas sel-sel osteosarcoma menunjukkan kebergantung 
terhadap saiz di mana nanopartikel kecil membawa kepada ketoksikan yang lebig 
tinggi.  
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SYNTHESIS OF SILICA NANOCOLLOIDS DRUG DELIVERY SYSTEM 
(DDS) BY MICELLE FORMATION APPROACH 
 
ABSTRACT 
 
 Silica nanoparticles (NPs) colloids were synthesized by using the micelle 
formation approach. This method was beneficial to produce monodispersed silica 
NPs with 20 nm to 160 nm size range by varying the reaction temperature and 
volume of co-solvent 2-butanol. Non-ionic surfactant Tween 80 was used to form 
micelles structure to entrapped drug and directly assists in the formation of sphere 
silica NPs colloids DDS. Compared to other methods, this method offers an easy 
process of drug loading whereby the drug molecules are directly entrapped inside the 
micelle structure before the formation of silica NPs. In this work, a small amount of 
surfactant was used without additional functionalizer. Besides, the success rate of 
drug entrapment in silica NPs was promising with removal of surfactant was 
completed by dialysis process which did not affect the properties of colloidal silica 
NPs. The optimum volume of Si precursor (VTMS) is 2 ml. Increase amount of Si 
precursor formed bimodal distribution. Two Tuberculosis drug, Isoniazid drug (water 
soluble) and Rifampicin drug (poor water soluble) were chosen as drug model. 
Stability of 50 nm and 70 nm silica NPs with entrapped Rifampicin drug (SiRIF) in 
various concentration of Sodium Chloride (NaCl) solution and mouse serum volume 
percentages were tested. Release profile of 50 nm and 70 nm SiRIF in various 
Phosphate buffer solution (PBS) and pH (pH 1.4, pH 7.4 and pH 6.8) were 
compared. 70 nm SiRIF showed slower release (31 %) compared to 50 nm SiRIF (44 
%) for 5 days. IC50 results from toxicity test WST-1 assays on osteosarcoma cells 
showed size dependent whereby smaller nanoparticles lead to higher toxicity.    
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 Research background 
Nanotechnology is a technology using nanosize matter (1-100 nm) that can be 
developed into devices and systems (Provenzale & Silva, 2009). The use of 
nanotechnology in medical application has been developed into a promising research 
area known as nanobiotechnology (Ahmed et al., 2012). The application of 
nanomaterials in medical field is very much welcomed especially in theranostic 
application. The main advantage of using nanomaterials is that its properties can be 
tuned or manipulated in order to meet the specific requirements of particular 
applications (Sumer & Gao, 2008). 
 
Recently, a lot of effort and attention are focusing on developing drug 
delivery system (DDS) based on nanotechnology because it is promising for targeted 
delivery to tissue of interest (Mamaeva et  al., 2012). DDS is a system that is capable 
of carrying agents and releasing them at a specific targeted area with a specific rate. 
The main objective of such systems is to control the dosage concentration and 
duration of drug administration without harming the patient while treating the 
patient’s health (Mishra et al., 2010, Mamaeva et al., 2012). The nanoparticles use in 
DDS must have characteristics such as biocompatible, stable in biological media, 
able to achieve high loading drug molecules, potential to be used in both hydrophilic 
and hydrophobic molecules, long circulation in blood, improve drug bioavailability, 
able to control the drug release and low toxicity (Barbe et al., 2004, Diab et al., 
2012, Koo et al., 2005, Mathuria, 2009, Ochekpe et al., 2009, Provenzale & Silva 
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2009). The candidates for DDS that have been intensively studied are polymeric 
micelles, polymer-based nanoparticles, lipid based nanoparticles (liposomes), 
dendrimers, magnetic nanoparticles, metals and inorganic nanoparticles (des Rieux et 
al., 2006, Kedar et al., 2010, Koo et al., 2005, Lawrence & Rees, 2012, Mishra et al., 
2010).  
 
Ceramic (inorganic) nanomaterials have advantages of high mechanical 
strength, good chemical stability, biocompatible, and resistance to microbial attack as 
compared to their organic (polymeric) counterparts (Rosenholm et al., 2010). Silica 
is a member of ceramic family that has potential to be used in biomedical 
applications such as DDS, biosensors, biomarkers, enzyme supporters etc. (Cellesi & 
Tirelli, 2006, Klichko et al., 2009, Santra et al., 2001). Silica based DDS has been 
widely studied because of its interesting properties such as well defined structures 
and surface properties appear to be a promising candidate as a DDS material. Silica 
is a very appealing material for DDS because it is relatively inexpensive, and 
chemically and thermally stable (Gadre & Gouma, 2006). Silica also offers the 
properties needed for nanoparticles based DDS such as low toxicity, biocompatible, 
high surface area,  hydrophilic and porous structure that are useful for tailoring the 
encapsulation of drugs or any biomolecules (Chen et al., 2012, Fuertes et al., 2010, 
Thomas et al., 2010).  
 
 Different types of silica have been studied as DDS such as mesoporous silica, 
silica aerogel and xerogel, sol gel-based silica, hollow silica, core-shell silica, 
colloidal silica and hybrid silica (Huang et al., 2011, Kortesuo et al., 1999, Liu et al., 
2011, Rosenholm et al., 2009, Slowing et al., 2007, Yang et al., 2008, Yunos et al., 
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2009, Zhou et al., 2010). There are a lot of methods to synthesis silica nanoparticles 
(silica NPs) for instance Stöber method, ionic liquid template, hydrothermal, 
microemulsion, reverse micelles/micelles (Finnie et al., 2007, Ghosh et al., 2012, Liu 
et al., 2006, Nozawa et al., 2005). All of these methods used sol-gel basic concept 
whereby hydrolysis and polymerization reaction processes are applied in different 
system (Nakazaki et al., 2008).  
 
1.2 Problem statement 
 Synthesis of silica NPs can be achieved by various methods such as 
conventional sol-gel method, microemulsion method and hydrothermal method. 
However, some of these methods have some limitations such as produce big size 
particles, particles agglomeration and complexity during washing and drying process 
(Andrade et al., 2013, Ganguly et al. 2010). Furthermore, the state of end product is 
in powder form which is only suitable as oral DDS (Kim et al. 2010). However, 
these methods are unsuitable to produce colloidal silica NPs which can be 
administered by different paths such as oral, parental, transdermal or by intravenous 
(IV) (Lawrence & Rees, 2012). In this work, silica NPs colloids was produced by 
combining sol-gel process with emulsion method whereby surfactant micelles acted 
as a structure template and indirectly facilitate in loading of drug molecules.  
 
There are a lot of hydrophobic drugs and not stable which make the 
administration of naked drug fail and ineffective. The limitations of the naked drug 
systems are their limited chemical and mechanical stability in biological condition 
and extreme condition. In addition, naked drugs also susceptible to microbiological 
contamination. In fact, inadequate control over drug-release rate also could lead to 
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ineffective drug administration (Rosenholm et  al., 2010). Besides, the incompetent 
of other carriers like polymeric materials make silica NPs colloids DDS as an 
excellent candidate for drug carrier. Polymeric materials only suitable for fast release 
instead of sustained release and easily agglomerate in biological media (Lin et al., 
2012, Vaishali et al., 2010).  
 
Several reported works have produced silica NPs DDS via absorption after 
silica NPs powder is produced (Andrade et al., 2013, Charnay et al., 2004, He et al., 
2010, Thomas et al., 2010, Zhang et al., 2010). Zhang et al. (2010) and He et al. 
(2010) immersed the silica NPs powder into drug solution to load drug into 
mesoporous structure of silica NPs. The weaknesses of this approach are unable to 
control the amount of drug absorb into the silica and could cause a fast release (He et 
al., 2010, Zhang et al., 2010). Other than that, reverse micelles formation also has 
been used to synthesize silica NPs DDS. Unfortunately drugs or molecules with poor 
water solubility have limitations in reverse micelles system (Abarkan and 
Doussineau, 2006, Bagwe et al., 2004). Research on direct drug impregnation into 
silica during synthesis is limited. Most researchers tend to load drugs after synthesis 
and focus more on pore structure and sizes (Parida et al., 2006, Santra et al., 2001). 
Some studies also have added functionalizers to link the molecule with silica NPs 
(Bagwe et al., 2004, Min et al., 2005). 
 
In this work, the problems of previous reported works could be overcome by 
synthesized silica NPs colloids using the micelles formation approach. In this 
method, a small amount of surfactant was used without additional functionalizer. 
Besides, the success rate of drug entrapment in silica NPs is promising with complete 
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removal of surfactant was carried out via dialysis process. This method offers an 
easy process of drug loading whereby the drug molecules are directly entrapped 
inside the micelle structure before formation of colloidal silica NPs. Silica NPs 
colloids entrapped Rifampicin (SiRIF) with uniform particle size distribution can be 
controlled by varying the synthesis parameters such as reaction temperature, amount 
of surfactant, butanol volume, and drug loading concentration.  In addition, stability 
of SiRIF in salt solution and biological media (NaCl and mouse serum) is also 
examined to assess the performance of SiRIF as drug carrier. Moreover, drug release 
properties are systematically studied by varying the concentration of phosphate 
buffer solution (PBS) and its pH. 
 
1.3 Objectives 
 The main objectives of this research are: 
i. To synthesis and characterize silica NPs colloids for drug delivery system. 
ii. To optimize entrapment of silica NPs colloids with Tuberculosis drug. 
iii. To study stability of silica NPs colloids with drug in biological media. 
iv. To study release properties of silica NPs colloids as drug delivery system. 
 
1.4 Thesis scope  
 This dissertation consists of five chapters. Chapter 1 discusses on the research 
background, problems statement and objectives of the research. Literature review of 
related works is discussed in Chapter 2. While in Chapter 3, experimental details and 
characterization used are explained in details. In Chapter 4, the results and 
discussions of this research are presented. Finally, conclusion and recommendations 
for future work are stated in Chapter 5. 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1  Introduction 
Nanotechnology can be defined as development of materials and devices in 
nanometer scales (1-100 nm) which involves fundamental understanding of physical 
properties of nanomaterials (Koo et al., 2005). Nanotechnology also has expand 
recently whereby nanoparticles based materials have been applied in biological 
applications such as diagnostic, bioimaging, gene transfer and drug delivery owing to 
their properties such as high surface area and size dependent qualities (Chang et al., 
2007, Tan et al., 2004). Drug delivery system (DDS) is a system that delivers the 
pharmaceuticals or therapeutics molecules to a target or organ of interest.  
 
Conventional DDS usually administers drug by oral route which initiates an 
early release of drugs (Strømme et al., 2009). Nanoparticles based DDS  could 
improve the conventional DDS by boosting the infiltration of the therapeutic 
molecules into blood barriers and prolong the transmission of drugs (Lopez et al. 
2009, Wanyika et al., 2011). DDS based on colloidal silica NPs is favourable 
because it is biocompatible, biodegradable, spherical shape, unique surface 
properties, tunable size and stable from aggregation (Fuertes et al., 2010, Guo et al., 
2008, Wang, 2009). 
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2.2 Silica nanoparticles (NPs)  
 Silica is one of the abundant earth’s crust which also exists in biological 
system (An et al., 2010). Synthetic amorphous silica has gained attention in the 
nanobiotechnology especially DDS. The properties such as tunable porosity, 
biocompatible, biodegradable, low toxicity and resistant in extreme environment  
make silica as a potential candidate for DDS (Nampi et al., 2012). There are three 
main types of silica which are all found under CAS No. 7631-86-9 as shown in 
Figure 2.1, (1) crystalline silica, (2) amorphous silica (naturally occurring or as a by-
product in the form of fused or fumed  silica), and (3) synthetic amorphous silica, 
including silica gel, precipitated silica, pyrogenic (fumed) silica and colloidal silica 
(sol) (Fruijtier-Pölloth, 2012). The difference between the amorphous and crystalline 
silica lies in the arrangement of the tetrahedral units. The arrangement of tetrahedral 
units for amorphous silica is random, whereby all oxygen at the corners are bonded 
with two nearby tetrahedra. Although there is no long range periodicity in the 
network there remains significant ordering at length scales well beyond the silica 
bond length (Fruijtier-Pölloth, 2012). 
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Figure 2.1: Various forms of silica (Fruijtier-Pölloth, 2012)
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2.2.1 Properties of Silica 
  There are several ways to produce amorphous silica.   Fumed or pyrolitic 
silica can be produced by pyrolysis process which uses high temperature (1200-1400 
C). In addition, colloidal, precipitates and mesoporous silica can be produced using 
hydrolysis and condensation reactions in aqueous solution or using hydrothermal 
process (Zhang et al., 2012). Unlike crystalline silica, amorphous silica has short-
range order and its structure is strongly dependent on kinetic and environmental 
factors because of a weak energy site. Schematic diagram in Figure 2.2 shows how 
amorphous silica structure is built from the siloxane framework architecture, which 
consists of combination of closed siloxane rings (Figure 2.2, Scheme 1), along with 
the concentration, pattern, and extent of hydrogen bonding of silanol groups 
(=Si−OH) that terminate the siloxane rings at the silica surface (Figure 2.2, Scheme 
2). Silica could contain relatively high concentration of surface-associated radicals 
(Figure 2.2, Scheme 3) as it has high surface area (Zhang et al., 2012).  
 
 Water adsorbs preferentially on the residual silanols which can be divided 
into three groups: isolated silanols, geminal silanols and vicinal silanols on the 
siloxanes. The most active silanol group is geminal silanols but their concentration 
on the surface is the lowest (10–12 %). Isolated silanols concentration is the highest 
(60–65 %), while vicinal silanols on the siloxanes (Si-O-Si) make the rest 
(Buszewski et al., 2012). Table 2.1 lists physical and chemical properties of different 
types of amorphous silica like pyrogenic, precipitated and colloidal silica (Fruijtier-
Pölloth, 2012). 
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Scheme 1. Schematic depicting the ring structure of amorphous silica and 
the amorphous silica surface after equilibration with hydroxyl groups
Scheme 2. Types of silanol groups that can exist on the amorphous silica 
surface
Scheme 3. Radicals that can exist on the amorphous silica surface
 
 
Figure 2.2: Schematic diagrams of amorphous silica structures and reaction on its 
surface (Zhang et al., 2012). 
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Table 2.1: Physical and chemical properties of different amorphous silica (Fruijtier-
Pölloth, 2012). 
Property [units] Pyrogenic Precipitated Colloidal 
Space group Not measurable for amorphous materials 
SiO2 content 
[wt%] 
≥ 99.8 > 95%; gel:>95% 
(dry) 
≥ 99.5 
Loss of drying [%] < 2.5 5-7; gel: 2-6 >> 2.5 
Melting point [°C] 1600-1725 1600-1725 1600-1725 
Density (g/cm
3
 at 
20 °C) 
2.2 2.2 2.2 
Water solubility 
(saturation) [mg/L] 
at 37 °C and pH 
7.1-7.4 
144-151: (15-68 at 
20 °C and pH 5.5-
6.6) 
141; gel: 127-141 Colloidal 
dispersion in water 
Specific surface 
area (SSA) 
50-400 30-500; gel: 250-
1000 
50-380 (spherical) 
~640 (porous) 
Zeta potential Negative Negative Usually negative, 
can be positive 
with certain 
stabilizer 
Behavior towards 
water 
Hydrophilic Hydrophilic Hydrophilic 
Porosity Microporous Meso- or 
macroporous 
- 
 
 
2.2.2 Structure of Silica NPs 
There are various types of silica structure that can be produced by 
manipulating the synthesis parameters as shown in Figure 2.3. Silica also can be 
classified according to its shapes such as mesoporous silica spheres, nanorods and 
nonporous silica like Stöber silica or hollow silica. Mesoporous silica is a common 
silica that has 2-50 nm pore size range. There are several mesoporous silica that can 
be classified according to their pore structures.  The most common mesophases in 
mesoporous silica with pore size between 2 and 5 nm are 2D hexagonal p6m, 3D 
cubic Ia3d and lamellar p2 which are related to MCM-41, MCM-48 and MCM-50 
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(Mobil Catalytic Material Number 41, 48 and 50) materials, respectively. For silica 
with larger pore size (6 to 20 nm wide) the 2D hexagonal p6mm structure is the most 
commonly reported for SBA-15 (Santa Barbara Amorphous-15) (Slowing et al., 
2010).Silica nanorods with different length and porosities can be produced by 
modifying the primary amine silane groups as shown in Figure 2.3 (Yu et al., 2011). 
  
 
 
Figure 2.3: (A) Transmission electron microscope (TEM) images of nonporous silica 
(Stöber), mesoporous silica (Meso S), mesoporous silica nanorods with aspect ratio 2 
(AR2), and mesoporous silica nanorods with aspect ratio 8 (AR8) and High 
resolution TEM (HRTEM) image of a nanoparticle from Meso S; scale bars = 200 
nm except in high-resolution image = 50 nm (Yu et al., 2012) 
 
 Nonporous silica like Stöber silica usually in colloidal forms (Hartlen et al., 
2008). Compared to other silica microstructure, this type of silica has a good 
monodispersity. The different of nonporous silica with porous silica lies in the final 
synthesis process. Porous silica is subjected to washing, filtering and calcination 
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process, while nonporous silica is maintained in colloidal form. Wang et al. (2010) 
synthesized porous silica hollow spheres by leaching the porous nickel silicate 
hollow spheres (Wang et al., 2010). While, Chen et al.   (2004) have used calcium 
carbonate (CaCO3) as a template that was removed by dissolved in hydrochloric acid 
(HCl) solution. Manipulation of the synthesis parameters can tune the size and shell 
thickness of porous hollow silica spheres. Other researchers  also have reported on 
using polystyrene (PS) as a template (Fu and He, 2011, Kato et al., 2010). 
 
2.2.3 Silica surface properties 
Silanol groups can form on the silica surface by two processes.  First, during 
synthesis process, whereby condensation and polymerization of silicic acid (Si(OH)4) 
occurs (Figure 2.4 (a)). Here, the reaction solution becomes supersaturated and 
transform into polymeric form. Then, it changes to colloidal containing spherical 
particles where silanol (Si≡OH) groups are present on the surface. However, 
concentration of silanol group presents on silica surface depends on the final state of 
silica itself either in colloids, gels or powder. Drying or applying heat treatment on 
the silica will produce silica gel or silica powder, which only contains some of the 
silanol groups on its surface because of water molecules, is removed. Secondly, in 
the present of water or aqueous solutions, the surface hydroxyl (OH
-
) groups are 
formed because of the rehydroxylation of dehyroxylated silica.  
 
The free valence electron becomes saturated with hydroxyl groups in an 
aqueous medium (Figure 2.4 (b)) because Silicon atoms tend to complete the 
tetrahedral formation on the surface. There are several types of hydroxyl (OH
-
) 
groups on the surface such as (1) isolated free (single silanols), ≡Si-OH; (2) geminal 
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free (geminal silanols or silanediols), =Si(OH)2 which is bonded by hydrogen bond 
(H-bonded single silanols, H-bonded geminals, and their H-bonded combinations) 
(Figure 2.5). On the silica surface also exists siloxane groups where the ≡Si-O-Si≡ 
bridges are formed with oxygen atoms on the surface. Also, there is structurally 
bound water inside the silica skeleton and very fine ultramicropores, d<1nm (d is the 
pore diameter), i.e. internal silanol groups (Zhuravlev, 2000). 
 
 
 
Figure 2.4: The formation of silanol groups on the silica surface: (a) Condensation 
polymerization; (b) Rehydroxylation (Zhuravlev, 2000) 
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Figure 2.5: Types of silanol groups and siloxane bridges on the surface of amorphous 
silica, and internal (OH
-
) groups. Q
n
 terminology is used in NMR, where n indicates 
the number of bridging bonds (-O-Si) tied to the central Si atom: Q4, surface 
siloxanes; Q
3
,single silanols; Q
2
, geminal silanols (silanediols) (Zhuravlev, 2000) 
 
2.2.3.1  Adsorption of organic molecules on silica surface 
Several organic molecules can be attached on the surface either by chemical 
bonding, hydrogen bonding, hydrophobic bonding or Van der Waals force to unique 
properties of silica surface (Parida et al., 2006). Cationic and nonionic surfactants are 
adsorbed on silica surface with hydrogen bonds. Sometimes, adsorption process of 
surfactants also is contributed by the polar part of surfactant itself. When silica 
surface is modified with alkali, the adsorption behaviour of cationic surfactant or 
polyethylene glycol changes due to changes in the characteristics of silica or 
modified silica surface. Cationic adsorption on silica in salt solution can be by 
electrostatic interaction with the alkyl tails and hence produces hydrophobic surface 
properties (Wang & Gu, 2005). Generally, nonionic surfactants have short 
hydrophilic oligo-oxyethylene headgroups that is relative to the size of the 
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hydrophobic tail and able to form bilayers and micellar structures on adsorption on 
surfaces of micellar structures. Sharma et al., (2010)  reported that the adsorbed 
nonionic surfactant micelles  provides steric repulsion between the particles which 
provides stability against aggregation.  
 
Polymers have polyfunctional groups that can attract to the hydroxyl groups 
of silica surface and hence can undergo adsorption. The adsorption of polymers 
depends on various factors such as the structure of polymer, surface structure, pH of 
the medium, temperature and the geometry of adsorbate (Yagüe et al., 2008). 
Polyethylene glycol (PEG) is a hydrophilic polymer that bond to silica through 
esterification on silica hydroxyl groups and silanol groups or attach by hydrogen 
bonding on the external surface of silica. Yagüe et al. (2008) and Yu et al. (2003) 
reported that adsorption of PEG could decrease adsorption of protein and 
consequently  increases the particles circulation half time (Yagüe et al., 2008, Xu et 
al., 2003).  
 
Hydrophobic and hydrophilic binding sites of silica have been studied by 
adsorptions of some natural biomolecules such as proteins. Proteins have 
heterogeneous surface which can be positively or negatively charged. Silica with 
negative charge surface tends to have ionic properties  with both hydrophilic (silanol 
groups) and hydrophobic surfaces. Hence, human serum protein (HSA) has 
nonspecific binding to silica by ionic attraction, hydrogen-bonding and non-polar  
(He, Zhang, et al., 2010). In a biological condition, the surfaces of nanomaterials can 
be modified by the adsorption of biomolecules that causes the formation of particle–
corona complex. The formation of a corona layer on the silica surface  inhibits 
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cytotoxicity and hemolysis (Shi et al., 2012). Adsorption of some biomolecules like 
lysozome and albumin is dependent on pH. Usually, the adsorption process occurs 
due to electrostatic interaction between adsorbate and adsorbent (Parida et al., 2006). 
  
2.2.3.2 Surface functionalization of silica 
Surface of silica can be modified by adding functionalize group on its surface 
in order to improve the surface properties especially to achieve minimum 
nanoparticles aggregation and reduces nanoparticles nonspecific binding. The surface 
can be modified either by mechanical, physical, chemical or biological 
functionalization (Hildebrand et al., 2006). There are three main ways for functional 
groups to be attached to the silica surface: reaction between organosilanes or organic 
molecules with silica surface functions,  chlorination of the silica surface followed by 
reaction of the Si–Cl with an appropriate functional molecule, or by incorporation of 
functional groups via sol–gel methodology followed by post-modification (Dash et 
al., 2008).  
 
2.3 Synthesis and fabrication of Silica NPs 
 Silica NPs can be produced by various methods starting from synthesis 
process until drying process which can end as different product. Figure 2.6 shows 
different process to produce different morphology and types of silica (Napierska et 
al., 2010).  
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Figure 2.6: General schematic diagram of silica synthesis processes (Napierska et al., 
2010) 
 
2.3.1 Sol-Gel process 
The sol-gel process is a wet-chemical method which has been widely used in 
producing metal oxides or ceramic materials (Rahman & Padavettan, 2012). The 
process starts from a colloidal solution called sol that acts as the precursor for 
formation of gel like aerogel or xerogel (after drying) depending on solvent removal 
process as shown in Figure 2.7 (Morosanova, 2012). The Si precursor undergoes 
hydrolysis and condensation reactions in the presence of water and alcohol as co-
solvent. Hydrolysis occurs and hydroxyl ions attach to Si precursor and produce 
alcohol as byproduct (equations 2.1 and 2.2). While, condensation occurs when 
silanol groups form siloxane bridge and release water and alcohol as byproducts 
(equations 2.3 and 2.4) (Gadre and Gouma, 2006, Radin et al., 2001). 
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Hydrolysis in water:  
 Si(OR)4 + H2O  HO-Si(OR)3 + R-OH                (2.1) 
 Si (OR)4 + 4H2O  Si(OH)4 + 4R-OH                                   (2.2) 
Condensation in water:  
 (OR)3Si-OH + HO-Si(OR)3 (OR)3Si-O-Si(OR)3 + H2O            (2.3)  
Condensation in alcohol:  
 (OR)3Si-OH + HO-Si(OR)3 (OR)3Si-O-Si(OR)3 + ROH           (2.4) 
 
 
Figure 2.7: The stages of silica sol-gel materials synthesis (Morosanova, 2012) 
 
 Through sol-gel process, monodispersed silica particles with sizes ranging 
from nanometer to micrometers can be produced by different synthesis approaches 
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such as microemulsion, Stöber method, ionic liquid template and hydrothermal 
method. All of these methods require extremely diluted reactions solutions (Kim et 
al. 2010). Silica NPs produced by the conventional sol-gel method usually have 
irregular morphology and slightly agglomerate. This condition is due to drying 
process especially to produce powder form silica. Besides, drying process to remove 
the water produces two different silica gel. Silica aerogel can be produced using a 
supercritical drying of the wet silica gel in an autoclave. While, silica xerogel is dried 
at ambient temperature which is much simpler and safer. Silica xerogel produced is 
denser compared to silica aerogel due to shrinkage of particles during drying process 
(Hæreid et al., 1996). On the other hand, Lindberg et al., (1995) have studied sol-gel 
silica NPs by varying synthesis parameters such as temperature, mixing and salt 
addition whereby monodispersed silica NPs from 50 to 700 nm were produced.   
 
2.3.1.1 Stöber process 
The Stöber process involves physical and chemistry processes to synthesis 
monodispersed silica NPs. The process was discovered by G.Kolbe in 1956 and 
redeveloped by Stöber et al. in 1968 (Tabatabaei, 2006). Usually tetraethyl 
orthosilicates (TEOS) as precursor is added into a large amount of water mixed with 
a low molar-mass alcohol solvent such as ethanol or methanol. Typically, this 
process is aided by catalyst either in basic or acidic condition. This method can 
produce monodispersed silica NPs with size varying between 50-2000 nm depending 
on types of precursor, alcohol  and volume ratio of reactant with water (Nozawa et 
al., 2005). It also can produce particles size up to 1 µm which has been reported in a 
modified technique (Lindberg et al., 1995). Nozawa et al. (2005) also have reported 
that particle size can be varied by using the seeded growth method where up to 2 µm 
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monodispersed silica can be produced by varying the precursor addition rate and 
striring rate.  
 
There are two paths of formation of monodispersed particles in Stober 
method either by LaMer mechanism or based on thermodynamic stabilization of 
particles (Guo et al., 2008). Lamer mechanism suggests that nucleation is the 
limiting factor in the growth process, whereby a constant number of nuclei further 
grows with increasing the precursor concentration (Malik et al., 2010). Meanwhile, 
for thermodynamic stabilization of particles, the nuclei forms continuously during 
the reaction and starts to aggregate with each other forming bigger particles. Guo et 
al. (2008) have synthesized monodispersed silica with size 10-100 nm by using the 
two-stage process (seed and growth) and regrowth approach of basic elemental silica 
precursor like TEOS, tetramethyl orthosilicate (TMOS) and tetrapropyl orthosilicate 
(TPOS).  
 
Figure 2.8 shows the monodispersed silica NPs produced using the regrowth 
of seed using TEOS precursor which the size of silica NPs can be increased by 
regrow the seed up to five times (Guo et al., 2008). Hartlen et al., (2008) also have 
produced monodispersed silica particles with size range 15-200 nm using the 
regrowth approach and arginine as the base catalyst. Yokoi et al. (2009) also have 
synthesized smaller silica with size range 8-35 nm based on the Stöber method but 
with different catalyst instead of ammonia which are arginine and lysine. This weak 
base induces slow hydrolysis process instead of fast hydrolysis process  in the 
conventional Stöber method (Yokoi et al., 2009). 
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Figure 2.8: Electron microscopy images of monodispersed silica NPs with various 
size ranges; (a) seed 18.5 ±  0.8 nm produced by the single stage growth, (b) the one 
stage regrowth seed 45.5 ± 1.3 nm, (c) the two stage regrowth seed 84 ± 2 nm, (d) 
three stage regrowth seed 117 ±  2.5 nm, (e) the four stage regrowth seed 141 ± 2.5 
nm and (f) the five stage regrowth seed (Guo et al., 2008) 
 
2.3.2 Hydrothermal growth method 
 Hydrothermal is a process that occurs either in single- or heterogeneous phase 
reaction in aqueous solution at temperature higher than room temperature and under 
pressure higher than 100 kPa (Ugheoke & Mamat, 2012). The process usually is 
carried out in a sealed container such as Teflon coated autoclave (Kim et al., 2010). 
During the synthesis process, the volatile organic solvent and byproducts like alcohol 
and water are evaporated from the system (Wei et al., 1999). The interaction between 
the Si precursor and the surfactant template introduced stabilizes the silica 
framework and prevents it from collapse causes by pressure and internal stress 
during the drying process. Several works have synthesized silica NPs using the 
hydrothermal growth method by varying the synthesis parameters such as 
temperature, amount of surfactant, types of organic solvent and hydrothermal time 
(Kim et al., 2010, Ganguly et al., 2010, Carrillo et al., 2011, Hu et al., 2011). 
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Conventional hydrothermal synthesis produces larger particle size which is around 
1µm (Kim et al., 2010). However, in the recent works surfactant template was 
introduced to control the particle size and the pore structure of particles (Kim et al., 
2010, Ganguly et al., 2010, Carrillo et al., 2011). Hydrothermal method is less 
favourable to produce silica NPs because it uses high temperature, expensive set up, 
and particles produced  are big and sometimes form irregular shape compared to 
other methods (Kim et al., 2010, Hu et al., 2011). But this method can produce silica 
particles with bigger pore size (Hu et al., 2011, Ganguly et al., 2010). Figure 2.9 
shows different surfactant used in hydrothermal growth method, whereby each 
surfactant produces silica NPs with different pores sizes. Sodium lauryl sulfate (SLS) 
surfactant produces large particles size distribution varies from 20 to 150 nm 
(Ganguly et al., 2010).  
 
 
Figure 2.9: TEM images of silica NPs produced by using different surfactants; (a) 
cetyl trimethyl ammonium bromide (CTAB), (b) Tergitol, (c) Sodium lauryl sulfate 
(SLS) and (d) polyethylene glycol (PEG) (Ganguly et al., 2010) 
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2.3.3 Ionic liquid template 
 Ionic liquids templates method (IL) is a method that involves any salt in 
liquid form at temperature below 100 °C. Typically, IL comprises of a large organic 
cation together with an organic or inorganic anion are present (Donato et al., 2008). 
Recently, room temperature ionic liquid (RTIL) method is favourable because 
organic salts with low melting points are used. RTIL is often regarded as a 
replacement for classical traditional molecular solvents due to their excellent 
properties such as high ionic conductivity, high polarity, negligible vapor pressure, 
and thermal stability. The greatest advantage of the RTIL is that it can be designed 
through altering the anions and cations. Therefore, RTIL microemulsion could have 
potential applications in material synthesis (Trewyn et al., 2004). Compared to 
conventional sol-gel method, IL offers longer aging time without shrinkage of the gel 
network.  
 
 This technique allows silica aerogel synthesis under mild chemical condition 
(Dai et al., 2000). Trewyn et al., (2004) reported the synthesis and characterization 
of series of mesoporous silica NPs (MSNs) materials by using different RTIL 
templates such as 1-tetradecyl-3- methylimidazolium bromide (C14MIMBr), 1-
hexadecyl-3- methylimidazolium bromide (C16MIMBr), 1-octadecyl-3-
methylimidazolium bromide (C18MIMBr), and 1-tetradecyloxymethyl-3-
methylimidazolium chloride (C14OCMIMCl) which produced various porous 
structures and morphologies such as spheres, ellipsoids, rods, and tubes as shown in 
Figure 2.10 (Trewyn et al., 2004). On the other hand, Zhao et al. (2009) have 
synthesized silica with different condition basic and acid using BmimBF4 ionic liquid 
